{"transactions":[{"id":916181,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":3422051,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":458855},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916180,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":1711025,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund IV, L.P. (\"Fund IV\"). Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM IV, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund IV, disclaims beneficial ownership of the shares held by Fund IV, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":229428},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916179,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":284392,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":38133},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916178,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":501219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":67207},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916177,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":6878,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":922},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916176,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":12123,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1626},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916175,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":3048192,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held of record by Foresite Capital VI-A, LLC (\"Fund VI-A\"). Foresite Capital VI-A Management, LLC (\"FC VI-A Management\") is the general partner of Fund VI-A and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FC VI-A Management, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and, other than Fund VI-A, disclaims beneficial ownership of the shares held by Fund VI-A, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":408725},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916174,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":282317,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37855},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916173,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":282317,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37855},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916172,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":282317,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund IV, L.P. (\"Fund IV\"). Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM IV, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund IV, disclaims beneficial ownership of the shares held by Fund IV, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37855},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916171,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":2602342,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":348942},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916170,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":5204684,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":697885},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916169,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":2502252,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund IV, L.P. (\"Fund IV\"). Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM IV, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund IV, disclaims beneficial ownership of the shares held by Fund IV, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":335521},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916168,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":10000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund IV, L.P. (\"Fund IV\"). Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM IV, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund IV, disclaims beneficial ownership of the shares held by Fund IV, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1340878},"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916167,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":55555,"price":18,"value":999990.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":1318983,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916166,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":408725,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held of record by Foresite Capital VI-A, LLC (\"Fund VI-A\"). Foresite Capital VI-A Management, LLC (\"FC VI-A Management\") is the general partner of Fund VI-A and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FC VI-A Management, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and, other than Fund VI-A, disclaims beneficial ownership of the shares held by Fund VI-A, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":408725,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916165,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":38133,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":425852,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916164,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":922,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":387719,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916163,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":37855,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":386797,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916162,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":348942,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":348942,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916161,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":458855,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":1263428,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916160,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":67207,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":804573,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916159,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":1626,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":737366,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916158,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":37855,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":735740,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916157,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":697885,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":697885,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916156,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":229428,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund IV, L.P. (\"Fund IV\"). Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM IV, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund IV, disclaims beneficial ownership of the shares held by Fund IV, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":1943682,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916155,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":37855,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund IV, L.P. (\"Fund IV\"). Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM IV, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund IV, disclaims beneficial ownership of the shares held by Fund IV, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":1714254,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916154,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":335521,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund IV, L.P. (\"Fund IV\"). Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM IV, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund IV, disclaims beneficial ownership of the shares held by Fund IV, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":1676399,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":916153,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67426,"kind":"organization","name":"Foresite Capital VI-A Management, LLC","position":7,"cik":"0001899218","reported_name":"Foresite Capital VI-A Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67427,"kind":"organization","name":"Foresite Capital VI-A, LLC","position":8,"cik":"0001899120","reported_name":"Foresite Capital VI-A, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T19:37:49.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":1340878,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by Foresite Capital Fund IV, L.P. (\"Fund IV\"). Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum (\"Tananbaum\"), the managing member of FCM IV, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a \"group\", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and, other than Fund IV, disclaims beneficial ownership of the shares held by Fund IV, except to the extent of such person's pecuniary interest in such securities."}],"balance_after":1340878,"source":{"system":"sec-edgar","filing":"0001104659-26-011662","document":"tm265543-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1899120/000110465926011662/tm265543-1_4seq1.xml","form_type":"4"}},{"id":1546777,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-05T14:15:04.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":520711,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. in exchange for (i) $2.5879 in cash per share, plus (ii) one non-transferable contingent value right per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-044187","document":"tm2411018-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000110465924044187/tm2411018-1_4seq1.xml","form_type":"4"}},{"id":1546776,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-05T14:15:04.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3525957,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. in exchange for (i) $2.5879 in cash per share, plus (ii) one non-transferable contingent value right per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-044187","document":"tm2411018-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000110465924044187/tm2411018-1_4seq1.xml","form_type":"4"}},{"id":1546775,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-05T14:15:04.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9671643,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. in exchange for (i) $2.5879 in cash per share, plus (ii) one non-transferable contingent value right per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"Fund IV\"). Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Dr. Tananbaum\"), in his capacity as the sole managing member of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM IV and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-044187","document":"tm2411018-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000110465924044187/tm2411018-1_4seq1.xml","form_type":"4"}},{"id":1898233,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":3,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":4,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":5,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":6,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T17:42:37.000Z","date":"2023-05-08","kind":"purchase","planned":false,"acquired":true,"shares":229044,"price":2.8,"value":641323.2,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. Dr. Tananbaum is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":520711,"source":{"system":"sec-edgar","filing":"0001209191-23-028527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919123028527/doc4.xml","form_type":"4"}},{"id":1898232,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":3,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":4,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":5,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":6,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T17:42:37.000Z","date":"2023-05-08","kind":"purchase","planned":false,"acquired":true,"shares":1550956,"price":2.8,"value":4342676.8,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund V, L.P. (\"Fund V\"). Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":3525957,"source":{"system":"sec-edgar","filing":"0001209191-23-028527","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919123028527/doc4.xml","form_type":"4"}},{"id":2000067,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":3,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":4,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":5,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":6,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-22T14:49:36.000Z","date":"2023-02-17","kind":"other","acquired":true,"shares":1100000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 17, 2023, the Issuer completed the acquisition of Kinnjiu Biompharma, Inc. (the \"Kinnjiu Acquisition\").  Foresite Capital Fund V, L.P. (\"Fund V\") was a shareholder of Kinnjiu Biompharma, Inc. and, as a result of the Kinnjiu Acquisition, Fund V received a combination of cash and 1,100,000 shares of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Received in exchange for 17,500,000 shares of Kinnjiu Biopharma, Inc. in connection with the Kinnjiu Acquisition.  The number of shares received was determined based on a volume weighted average price per share of $6.7757."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for 17,500,000 shares of Kinnjiu Biopharma, Inc. in connection with the Kinnjiu Acquisition.  The number of shares received was determined based on a volume weighted average price per share of $6.7757."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Fund V. Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1975001,"source":{"system":"sec-edgar","filing":"0001209191-23-011565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919123011565/doc4.xml","form_type":"4"}},{"id":2526411,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":1,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":2,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":3,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":5,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":6,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-03T20:17:40.000Z","date":"2021-11-01","kind":"other","acquired":true,"shares":8276,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents shares received by the James B. Tananbaum and Dana Shonfeld Tananbaum Family Trust pursuant to pro rata distributions by Fund III and FCM III, for no consideration, of shares of the Issuer's Common Stock to their respective partners or members, as applicable. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held of record by a family trust for which Mr. Tananbaum is a trustee. Each of the Reporting Persons disclaims the existence of a \"group\" and, other than Mr. Tananbaum, disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":8276,"source":{"system":"sec-edgar","filing":"0001209191-21-062697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919121062697/doc4.xml","form_type":"4"}},{"id":2526410,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":1,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":2,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":3,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":5,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":6,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-03T20:17:40.000Z","date":"2021-11-01","kind":"other","acquired":false,"shares":1954904,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 1, 2021, Foresite Capital Fund III, L.P. (\"Fund III\") distributed, for no consideration, 1,954,904 shares of the Issuer's Common Stock (the \"Fund III Shares\") to its limited partners and to Foresite Capital Management III, LLC (\"FCM III\"), the general partner of Fund III, representing each such partner's pro rata interest in such Fund III Shares. On the same date, FCM III distributed, for no consideration, the Fund III Shares it received in the distribution by Fund III to its members, representing each such member's pro rata interest in such Fund III Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Fund III. FCM III is the general partner of Fund III, may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Mr. Tananbaum\") is the sole managing member of FCM III and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-062697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919121062697/doc4.xml","form_type":"4"}},{"id":2951991,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":48376,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1.00335008 share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1.00335008 share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1.00335008 share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":48538},"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2951990,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":145128,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1.00335008 share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1.00335008 share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1.00335008 share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":145614},"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2951989,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":157222,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1.00335008 share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1.00335008 share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of the issuer's Series C Preferred Stock automatically converted into 1.00335008 share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":157748},"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2951988,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":18641,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of the issuer's Series B Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of the issuer's Series B Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of the issuer's Series B Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund V, L.P. (\"Fund V\").  Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18641},"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2951987,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":55922,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of the issuer's Series B Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of the issuer's Series B Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of the issuer's Series B Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund V, L.P. (\"Fund V\").  Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":55922},"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2951986,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":2666002,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of the issuer's Series B Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of the issuer's Series B Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of the issuer's Series B Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund V, L.P. (\"Fund V\").  Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2666002},"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2951985,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":99488,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of the issuer's Series A Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of the issuer's Series A Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of the issuer's Series A Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"Fund IV\").  Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Dr. Tananbaum\"), in his capacity as the sole managing member of FCM IV, may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM IV and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":99488},"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2951984,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":298465,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of the issuer's Series A Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of the issuer's Series A Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of the issuer's Series A Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"Fund IV\").  Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Dr. Tananbaum\"), in his capacity as the sole managing member of FCM IV, may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM IV and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":298465},"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2951983,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":6347893,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of the issuer's Series A Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of the issuer's Series A Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of the issuer's Series A Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the issuer's public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"Fund IV\").  Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Dr. Tananbaum\"), in his capacity as the sole managing member of FCM IV, may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM IV and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6347893},"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2951982,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":true,"shares":166667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":291667,"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2951981,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":true,"shares":500001,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund V, L.P. (\"Fund V\").  Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":875001,"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2951980,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-09T13:35:42.000Z","date":"2020-12-07","kind":"exercise","acquired":true,"shares":9171643,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"Fund IV\").  Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Dr. Tananbaum\"), in his capacity as the sole managing member of FCM IV, may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM IV and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":9671643,"source":{"system":"sec-edgar","filing":"0001209191-20-062449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120062449/doc4.xml","form_type":"4"}},{"id":2956726,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-04T20:57:54.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":125000,"price":20,"value":2500000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Opportunity Fund V, L.P. (\"Opportunity Fund V\"). Foresite Capital Opportunity Management V, LLC (\"FCOM V\") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCOM V and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCOM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCOM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001209191-20-061877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120061877/doc4.xml","form_type":"4"}},{"id":2956725,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-04T20:57:54.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":375000,"price":20,"value":7500000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund V, L.P. (\"Fund V\").  Foresite Capital Management V, LLC (\"FCM V\") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Dr. Tananbaum\") is the sole managing member of FCM V and may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM V and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM V or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":375000,"source":{"system":"sec-edgar","filing":"0001209191-20-061877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120061877/doc4.xml","form_type":"4"}},{"id":2956724,"issuer":{"id":92187,"kind":"organization","name":"Kinnate Biopharma Inc.","symbol":"KNTE"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":3,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":4,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25100,"kind":"organization","name":"Foresite Capital Opportunity Management V, LLC","position":5,"cik":"0001792207","reported_name":"Foresite Capital Opportunity Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25101,"kind":"organization","name":"Foresite Capital Opportunity Fund V, L.P.","position":6,"cik":"0001792205","reported_name":"Foresite Capital Opportunity Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-04T20:57:54.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":500000,"price":20,"value":10000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"Fund IV\").  Foresite Capital Management IV, LLC (\"FCM IV\") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Dr. Tananbaum\"), in his capacity as the sole managing member of FCM IV, may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM IV and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV or Dr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001209191-20-061877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797768/000120919120061877/doc4.xml","form_type":"4"}},{"id":3238370,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":3,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":5,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":6,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T22:01:47.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":271767,"price":17.07,"value":4639062.69,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general partner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1229633,"source":{"system":"sec-edgar","filing":"0001209191-20-014562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919120014562/doc4.xml","form_type":"4"}},{"id":3238369,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":3,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":5,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":6,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T22:01:47.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":425457,"price":17.07,"value":7262550.99,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1925020,"source":{"system":"sec-edgar","filing":"0001209191-20-014562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919120014562/doc4.xml","form_type":"4"}},{"id":3238368,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":3,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":5,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":6,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T22:01:47.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":302776,"price":17.07,"value":5168386.32,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund II, L.P. (\"FCF II\"). Foresite Capital Management II, LLC (\"FCM II\"), the general partner of FCF II, may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM II, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM II and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM II and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1369938,"source":{"system":"sec-edgar","filing":"0001209191-20-014562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919120014562/doc4.xml","form_type":"4"}},{"id":3332599,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Put Option (obligation to purchase)","published_at":"2019-12-23T23:05:53.000Z","date":"2019-12-20","kind":"other","acquired":false,"shares":289,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option may be exercised at any time on or prior to the expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Before the reporting persons became subject to Section 16, FCF IV wrote a put option for 100,500 shares of the Issuer's common stock. The put option has now been exercised in its entirety."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The options are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general partner of FCF IV, may be deemed to have sole voting and dispositive power over these options. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM IV, may be deemed to have sole voting and dispositive power over these options. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these options except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is the beneficial owner of these options for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"exercise_price":30,"expiration_date":"2019-12-20","underlying":"Common Stock","underlying_shares":28900},"source":{"system":"sec-edgar","filing":"0001209191-19-061835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119061835/doc4.xml","form_type":"4"}},{"id":3332598,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-23T23:05:53.000Z","date":"2019-12-20","kind":"other","acquired":true,"shares":28900,"price":30,"value":867000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1501400,"source":{"system":"sec-edgar","filing":"0001209191-19-061835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119061835/doc4.xml","form_type":"4"}},{"id":3351020,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Put Option (obligation to purchase)","published_at":"2019-12-06T00:03:19.000Z","date":"2019-12-03","kind":"other","acquired":false,"shares":266,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option may be exercised at any time on or prior to the expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Before the reporting persons became subject to Section 16, FCF IV wrote a put option for 100,500 shares of the Issuer's common stock. The put option has now been exercised for an aggregate of 71,600 shares. A portion of the short put remains open, and therefore FCF IV may be obligated to purchase an additional 28,900 shares of the Issuer's common stock in the event the holder of the put option elects to exercise the remainder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The options are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general partner of FCF IV, may be deemed to have sole voting and dispositive power over these options. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM IV, may be deemed to have sole voting and dispositive power over these options. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these options except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is the beneficial owner of these options for purposes of Section 16 or any other purpose."}],"balance_after":289,"derivative":{"exercise_price":30,"expiration_date":"2019-12-20","underlying":"Common Stock","underlying_shares":26600},"source":{"system":"sec-edgar","filing":"0001209191-19-059392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119059392/doc4.xml","form_type":"4"}},{"id":3351019,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Put Option (obligation to purchase)","published_at":"2019-12-06T00:03:19.000Z","date":"2019-11-26","kind":"other","acquired":false,"shares":44,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option may be exercised at any time on or prior to the expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Before the reporting persons became subject to Section 16, FCF IV wrote a put option for 100,500 shares of the Issuer's common stock. The put option has now been exercised for an aggregate of 45,000 shares. A portion of the short put remains open, and therefore FCF IV may be obligated to purchase an additional 55,500 shares of the Issuer's common stock in the event the holder of the put option elects to exercise the remainder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The options are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general partner of FCF IV, may be deemed to have sole voting and dispositive power over these options. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM IV, may be deemed to have sole voting and dispositive power over these options. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these options except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is the beneficial owner of these options for purposes of Section 16 or any other purpose."}],"balance_after":555,"derivative":{"exercise_price":30,"expiration_date":"2019-12-20","underlying":"Common Stock","underlying_shares":4400},"source":{"system":"sec-edgar","filing":"0001209191-19-059392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119059392/doc4.xml","form_type":"4"}},{"id":3351018,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-06T00:03:19.000Z","date":"2019-12-03","kind":"other","acquired":true,"shares":26600,"price":30,"value":798000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1472500,"source":{"system":"sec-edgar","filing":"0001209191-19-059392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119059392/doc4.xml","form_type":"4"}},{"id":3351017,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-06T00:03:19.000Z","date":"2019-11-26","kind":"other","acquired":true,"shares":4400,"price":30,"value":132000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1445900,"source":{"system":"sec-edgar","filing":"0001209191-19-059392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119059392/doc4.xml","form_type":"4"}},{"id":3368562,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Put Option (obligation to purchase)","published_at":"2019-11-18T23:11:49.000Z","date":"2019-11-15","kind":"other","acquired":false,"shares":199,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option may be exercised at any time on or prior to the expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Before the reporting persons became subject to Section 16, FCF IV wrote a put option for 100,500 shares of the Issuer's common stock. The put option has now been exercised for an aggregate of 40,600 shares. A portion of the short put remains open, and therefore FCF IV may be obligated to purchase an additional 59,900 shares of the Issuer's common stock in the event the holder of the put option elects to exercise the remainder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The options are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general partner of FCF IV, may be deemed to have sole voting and dispositive power over these options. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM IV, may be deemed to have sole voting and dispositive power over these options. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these options except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is the beneficial owner of these options for purposes of Section 16 or any other purpose."}],"balance_after":599,"derivative":{"exercise_price":30,"expiration_date":"2019-12-20","underlying":"Common Stock","underlying_shares":19900},"source":{"system":"sec-edgar","filing":"0001209191-19-057029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119057029/doc4.xml","form_type":"4"}},{"id":3368561,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Put Option (obligation to purchase)","published_at":"2019-11-18T23:11:49.000Z","date":"2019-11-14","kind":"other","acquired":false,"shares":57,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option may be exercised at any time on or prior to the expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Before the reporting persons became subject to Section 16, FCF IV wrote a put option for 100,500 shares of the Issuer's common stock. The put option has now been exercised for an aggregate of 20,700 shares. A portion of the short put remains open, and therefore FCF IV may be obligated to purchase an additional 79,800 shares of the Issuer's common stock in the event the holder of the put option elects to exercise the remainder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The options are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general partner of FCF IV, may be deemed to have sole voting and dispositive power over these options. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM IV, may be deemed to have sole voting and dispositive power over these options. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these options except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is the beneficial owner of these options for purposes of Section 16 or any other purpose."}],"balance_after":798,"derivative":{"exercise_price":30,"expiration_date":"2019-12-20","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-19-057029","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119057029/doc4.xml","form_type":"4"}},{"id":3368560,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-18T23:11:49.000Z","date":"2019-11-15","kind":"other","acquired":true,"shares":19900,"price":30,"value":597000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1441500,"source":{"system":"sec-edgar","filing":"0001209191-19-057029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119057029/doc4.xml","form_type":"4"}},{"id":3368559,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-18T23:11:49.000Z","date":"2019-11-14","kind":"other","acquired":true,"shares":5700,"price":30,"value":171000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1421600,"source":{"system":"sec-edgar","filing":"0001209191-19-057029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119057029/doc4.xml","form_type":"4"}},{"id":3374693,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Put Option (obligation to purchase)","published_at":"2019-11-12T19:52:30.000Z","date":"2019-11-07","kind":"other","acquired":false,"shares":150,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option may be exercised at any time on or prior to the expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Before the reporting persons became subject to Section 16, FCF IV wrote a put option for 100,500 shares of the Issuer's common stock. The put option was partially exercised by its holder for 15,000 shares.  A portion of the short put remains open, and therefore FCF IV may be obligated to purchase an additional 85,500 shares of the Issuer's common stock in the event the holder of the put option elects to exercise the remainder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The options are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general partner of FCF IV, may be deemed to have sole voting and dispositive power over these options. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM IV, may be deemed to have sole voting and dispositive power over these options. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these options except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is the beneficial owner of these options for purposes of Section 16 or any other purpose."}],"balance_after":855,"derivative":{"exercise_price":30,"expiration_date":"2019-12-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-055965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119055965/doc4.xml","form_type":"4"}},{"id":3374692,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":1,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":2,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":3,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-12T19:52:30.000Z","date":"2019-11-07","kind":"other","acquired":true,"shares":15000,"price":30,"value":450000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1415900,"source":{"system":"sec-edgar","filing":"0001209191-19-055965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119055965/doc4.xml","form_type":"4"}},{"id":3420668,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-07T00:28:16.000Z","date":"2019-09-05","kind":"purchase","acquired":true,"shares":15700,"price":18.42,"value":289194.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $18.25 to $18.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2350477,"source":{"system":"sec-edgar","filing":"0001209191-19-048830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048830/doc4.xml","form_type":"4"}},{"id":3420667,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-07T00:28:16.000Z","date":"2019-09-04","kind":"purchase","acquired":true,"shares":90900,"price":18.48,"value":1679832.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $18.12 to $18.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general partner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1400900,"source":{"system":"sec-edgar","filing":"0001209191-19-048830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048830/doc4.xml","form_type":"4"}},{"id":3420666,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-07T00:28:16.000Z","date":"2019-09-04","kind":"purchase","acquired":true,"shares":9300,"price":18.48,"value":171864.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $18.12 to $18.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2334777,"source":{"system":"sec-edgar","filing":"0001209191-19-048830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048830/doc4.xml","form_type":"4"}},{"id":3423396,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-05T00:38:56.000Z","date":"2019-09-03","kind":"purchase","acquired":true,"shares":15100,"price":21.45,"value":323895.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $21.23 to $21.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2325477,"source":{"system":"sec-edgar","filing":"0001209191-19-048394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048394/doc4.xml","form_type":"4"}},{"id":3423395,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-05T00:38:56.000Z","date":"2019-09-03","kind":"purchase","acquired":true,"shares":34900,"price":20.54,"value":716846.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $20.23 to $21.20. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2310377,"source":{"system":"sec-edgar","filing":"0001209191-19-048394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048394/doc4.xml","form_type":"4"}},{"id":3423394,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-05T00:38:56.000Z","date":"2019-08-30","kind":"purchase","acquired":true,"shares":25000,"price":21.36,"value":534000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $21.00 to $21.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2275477,"source":{"system":"sec-edgar","filing":"0001209191-19-048394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048394/doc4.xml","form_type":"4"}},{"id":3430270,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-24T00:52:41.000Z","date":"2019-08-23","kind":"purchase","acquired":true,"shares":38300,"price":23.42,"value":896986.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $23.295 to $23.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2250477,"source":{"system":"sec-edgar","filing":"0001209191-19-047387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119047387/doc4.xml","form_type":"4"}},{"id":3430269,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-24T00:52:41.000Z","date":"2019-08-22","kind":"purchase","acquired":true,"shares":6700,"price":23.68,"value":158656.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $23.48 to $23.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2212177,"source":{"system":"sec-edgar","filing":"0001209191-19-047387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119047387/doc4.xml","form_type":"4"}},{"id":3430268,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-24T00:52:41.000Z","date":"2019-08-21","kind":"purchase","acquired":true,"shares":1153,"price":23.25,"value":26807.25,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2205477,"source":{"system":"sec-edgar","filing":"0001209191-19-047387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119047387/doc4.xml","form_type":"4"}},{"id":3433285,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-21T00:27:57.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":50000,"price":23.21,"value":1160500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $22.82 to $23.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2204324,"source":{"system":"sec-edgar","filing":"0001209191-19-046913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046913/doc4.xml","form_type":"4"}},{"id":3433284,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-21T00:27:57.000Z","date":"2019-08-19","kind":"purchase","acquired":true,"shares":3847,"price":23.34,"value":89788.98,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $23.22 to $23.42. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2154324,"source":{"system":"sec-edgar","filing":"0001209191-19-046913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046913/doc4.xml","form_type":"4"}},{"id":3433283,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-21T00:27:57.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":100000,"price":24.23,"value":2423000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $23.73 to $24.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2150477,"source":{"system":"sec-edgar","filing":"0001209191-19-046913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046913/doc4.xml","form_type":"4"}},{"id":3438840,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-15T00:15:51.000Z","date":"2019-08-14","kind":"purchase","acquired":true,"shares":100000,"price":23.73,"value":2373000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $23.50 to $24.05. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2050477,"source":{"system":"sec-edgar","filing":"0001209191-19-046012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046012/doc4.xml","form_type":"4"}},{"id":3438839,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-15T00:15:51.000Z","date":"2019-08-13","kind":"purchase","acquired":true,"shares":178903,"price":25.52,"value":4565604.56,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $25.16 to $25.70. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1310000,"source":{"system":"sec-edgar","filing":"0001209191-19-046012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046012/doc4.xml","form_type":"4"}},{"id":3438838,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-15T00:15:51.000Z","date":"2019-08-13","kind":"purchase","acquired":true,"shares":71097,"price":24.92,"value":1771737.24,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $24.15 to $25.15. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1131097,"source":{"system":"sec-edgar","filing":"0001209191-19-046012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046012/doc4.xml","form_type":"4"}},{"id":3438837,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-15T00:15:51.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":189555,"price":24.43,"value":4630828.65,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $23.99 to $24.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1060000,"source":{"system":"sec-edgar","filing":"0001209191-19-046012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046012/doc4.xml","form_type":"4"}}]}